Effect of nifedipine on plasma renin, aldosterone and catecholamines in arterial hypertension. 1979

O L Pedersen, and E Mikkelsen, and N J Christensen, and H J Kornerup, and E B Pedersen

Acute sublingual administration of nifedipine 10--20 mg to 13 hypertensive patients caused a rapid decrease in blood pressure (BP) and a concomitant increase in heart rate (HR), plasma noradrenaline (NA) and plasma renin activity (PRA); there was no significant change in plasma adrenaline (A) or aldosterone (ALDO). Basal PRA was the major determinant of the rise in PRA, as a close correlation was present between the basal value and the increase caused by nifedipine (r = 0.92), p less than 0.001). The rise in PRA was also correlated with the plasma concentration of nifedipine after 60 min (r = 0.80, p less than 0.01), but it was not correlated with the decrease in BP, the rise in HR or the increase in NA. Nifedipine 30--60 mg daily for 6 weeks caused a reduction in mean BP from 133 to 113 mmHg (p less than 0.001). Body weight and serum potassium decreased but no consistent change was noted in NA, PRA, ALDO or 24 h-excretion of catecholamines. A significant correlation was present between the change in NA and that in PRA (r = 0.74, p less than 0.01). The alterations in the various parameters in the acute and chronic studies were not correlated. The findings indicate that different regulatory mechanisms are activated during acute and chronic administration of nifedipine. It is suggested that an initial rise in sympathetic activity gradually decreases during prolonged therapy, but it still remains a determinant of PRA.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

O L Pedersen, and E Mikkelsen, and N J Christensen, and H J Kornerup, and E B Pedersen
November 1979, European journal of clinical pharmacology,
O L Pedersen, and E Mikkelsen, and N J Christensen, and H J Kornerup, and E B Pedersen
June 1982, Polski tygodnik lekarski (Warsaw, Poland : 1960),
O L Pedersen, and E Mikkelsen, and N J Christensen, and H J Kornerup, and E B Pedersen
May 1980, Klinische Wochenschrift,
O L Pedersen, and E Mikkelsen, and N J Christensen, and H J Kornerup, and E B Pedersen
January 1980, Postgraduate medical journal,
O L Pedersen, and E Mikkelsen, and N J Christensen, and H J Kornerup, and E B Pedersen
January 1978, Bollettino della Societa italiana di cardiologia,
O L Pedersen, and E Mikkelsen, and N J Christensen, and H J Kornerup, and E B Pedersen
January 1965, Bruxelles medical,
O L Pedersen, and E Mikkelsen, and N J Christensen, and H J Kornerup, and E B Pedersen
January 1979, Acta medica Scandinavica. Supplementum,
O L Pedersen, and E Mikkelsen, and N J Christensen, and H J Kornerup, and E B Pedersen
January 1989, Polski tygodnik lekarski (Warsaw, Poland : 1960),
O L Pedersen, and E Mikkelsen, and N J Christensen, and H J Kornerup, and E B Pedersen
December 1994, Journal of human hypertension,
O L Pedersen, and E Mikkelsen, and N J Christensen, and H J Kornerup, and E B Pedersen
July 1977, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Copied contents to your clipboard!